Treatment of refractory angina in patients not suitable for revascularization. - Wikidata - wikimedia - TriplyDB

Treatment of refractory angina in patients not suitable for revascularization.

Treatment of refractory angina in patients not suitable for revascularization.

http://www.wikidata.org/entity/Q38173640

about

Wars2 is a determinant of angiogenesis.Evaluation of extracorporeal shock wave therapy for refractory angina pectoris with quantitative analysis using cardiac magnetic resonance imaging: a short communication.Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.Fatty acid carbon is essential for dNTP synthesis in endothelial cells Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients With Stable Ischemic Heart Failure Is Preserved.Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial Efficacy of Enhanced External Counterpulsation in Patients With Chronic Refractory Angina on Canadian Cardiovascular Society (CCS) Angina Class: An Updated Meta-Analysis.Current State of Stem Cell Therapy for Ischemic Heart Disease.Almanac 2015: coronary artery disease.Cardiovascular Gene Therapy: Past, Present, and Future.Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature.AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium.Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study.A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T.Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome Can endothelial progenitor cells treat patients with refractory angina?Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.Angiogenic gene therapy in cardiovascular diseases: dream or vision?The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.Cell Therapy for Refractory Angina: A Reappraisal.Refractory angina revisited: stem cells for a growing unmet clinical need?A Novel Intra-aortic Device Designed for Coronary Blood Flow Amplification in Unrevascularizable Patients.Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)

P2860

Q27339787-18356784-5DC5-4C29-8591-F178CCBF63CB Q30383943-BB50C325-9BC9-4FD7-BCB6-C81E916FA851 Q30729604-B7291E8E-9FA7-4315-A28B-F79B87C48361 Q35548351-C6DB6EAF-CB66-4BEC-959A-4F1263484F58 Q36831811-673ACCCB-B548-4C6B-915E-927E431156D1 Q37217902-6DE16841-2DC4-49D7-A285-9A57B2F178DB Q37320291-481278AA-8B24-4B7A-8CF6-23F04580F542 Q37328519-47EDA26A-EC9F-4328-935D-90C0D3016656 Q38697092-ABFD0F78-F60F-4A86-BF19-568B0A1C7787 Q38714574-1AB035B6-9200-4CB2-9D5B-104283B00906 Q38733395-D247047C-4F75-470A-A8FE-EB0A3C8CD300 Q39000547-630F8D2A-E2E4-4B37-9BAE-9AB4BE0CF160 Q39172716-8E00C011-9004-4C80-934B-17D7D8DD5C22 Q39790202-827C4CB3-5F9A-452D-BC4F-53281765F792 Q40535232-D3A089E9-716A-4564-8769-FBA5A3AB5D88 Q41550812-89701982-A80C-4DCE-83AC-17AE59631F95 Q43092460-BF796206-8E3E-4DD3-89F5-3EC74A3E862E Q45252610-0FDCC41A-70EA-454E-A10B-2961FC4E3F7D Q45863499-648F582E-AE8C-4FFC-8A3E-97483C6C39D8 Q46102792-D30F9655-10A4-4E76-B4A4-34239B6F582C Q47190217-54FEC1B0-0D51-4C5D-B922-7F3D4A8080A1 Q48155875-960D5772-5E20-481B-A245-6B6609D3BCB3 Q50120552-718CA608-70E3-4594-B673-06E5E9AFA317 Q50633215-AE29DA18-6BFF-407B-A418-2E5691E5810A Q58741622-E9622556-B71E-4AE6-85DE-C78419598916

P2860

Treatment of refractory angina in patients not suitable for revascularization.

http://www.wikidata.org/entity/Q38173640

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of refractory angina in patients not suitable for revascularization.

@en

type

label

Treatment of refractory angina in patients not suitable for revascularization.

@en

prefLabel

Treatment of refractory angina in patients not suitable for revascularization.

@en

P1433

Q38173640-0E8605AB-B231-4E45-8848-7F4BF0139A48

P1476

Q38173640-3A50A55B-1769-413D-8CFF-0D0AE0A676BB

P2093

Q38173640-10AD8A9A-ECD2-4D98-9ABD-C14FEC907A93

Q38173640-5EC4BE4E-C22D-47EC-AB0A-A52DBBE8AB03

Q38173640-E558C1E8-CEC6-4BA3-AB70-5755A422561D

P2860

Q38173640-02588A97-8036-4476-9682-7E0CD7656A0A

Q38173640-02FAD33E-AE3D-4F46-8963-C29E78ADD847

Q38173640-04514E12-84AC-4D47-9F6F-1898EF028687

Q38173640-0587E9B0-55AC-4FF2-8F59-1F59410F62DA

Q38173640-06F5B031-5D9F-48F5-A4CE-CFE61DBC0042

Q38173640-0963B673-3A77-4F03-AD44-5E5B8E04D131

Q38173640-0F08BA60-2759-4EC0-962B-455D923CF5B7

Q38173640-0FCAC4A6-3DE5-42E2-AE67-D22104081DDA

Q38173640-1085F8DB-CE54-4CD8-BA97-EF5FF7A9C8A4

Q38173640-10A690D5-903A-4C48-B5E5-9F5D16C9E1E6

P304

Q38173640-7941AFB4-D9D2-4E3A-9F5B-12F7D74061EB

P31

Q38173640-2EE11766-2B66-46BC-BEB7-2570D02D0818

P356

Q38173640-90EE23C0-060F-4807-8D6D-68FF294E057C

P407

Q38173640-5E408F3F-4935-4D78-AAC4-132C63FF42D1

P433

Q38173640-A41F8956-4B28-4BB1-A66B-18BB14921C92

P478

Q38173640-83A7A21D-1037-4106-825C-ADE96200D43C

P577

Q38173640-E0033C4D-AE9E-4221-A174-08FCE220BCE5

P5875

Q38173640-33699D96-93B0-45A6-8689-24A106B779BE

P698

Q38173640-89C35226-58A8-4CE1-8F4B-3F2210C906A8

P921

Q38173640-DE936931-20A5-49C2-856F-2166B8F03BFB

P356

NRCARDIO.2013.200

P1433

Nature Reviews Cardiology

P1476

Treatment of refractory angina in patients not suitable for revascularization.

@en

P2093

Daniel Satran

http://www.w3.org/2001/XMLSchema#string

E Marc Jolicoeur

http://www.w3.org/2001/XMLSchema#string

Timothy D Henry

http://www.w3.org/2001/XMLSchema#string

P2860

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome?

Acute anti-ischemic effect of testosterone in men with coronary artery disease

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia

A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease.

Human embryonic stem cells derived by somatic cell nuclear transfer.

P304

78-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2013.200

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259455594

http://www.w3.org/2001/XMLSchema#string

P698

24366073

http://www.w3.org/2001/XMLSchema#string

P921

revascularization